To help focus on changes linked to the pro-survival activity of FGF-2, we repeated the quantitative phosphoproteomic experiments in the presence of an alternate stimulus, stem cell factor (SCF) (Supplementary Table S3), which is involved in the proliferation (29–31), but not survival, of lung cancer cells (our unpublished observations). This evidence concerns the gene KITLG and lung carcinoma.